Table of Contents Table of Contents
Previous Page  25 / 78 Next Page
Information
Show Menu
Previous Page 25 / 78 Next Page
Page Background

DCMS online

. org

Northeast Florida Medicine

Vol. 66, No. 4 2015

25

Inflammatory Bowel Disease

duration of colonic involvement.

51

It is now believed that

the risk of developing CRC in UC and CD is identical.

52

Traditionally, interval colonoscopies with random

biopsies of normal mucosa and targeted biopsies of

suspicious lesions have been recommended for dysplasia

surveillance in patients with chronic colitis. Newer methods

aimed at detecting dysplastic mucosa have been studied.

High-definition white light endoscopy and enhanced

magnification colonoscopy have been used to increase

the yield in detecting dysplasia. Recent colitis surveillance

studies showed that high-definition colonoscopy improved

dysplasia detection compared to standard definition.

53

Chromoendoscopy is a dye-spraying technique that

highlights the borders and surface architecture of

neoplastic lesions (pit pattern). Chromoendoscopy helps

in unmasking and delineating subtle lesions and aids in the

differentiation of neoplastic and non-neoplastic tissue.

54

With this method, random biopsies of apparently normal

mucosa are of negligible additional value.

55,56

Diagnostic

yield of chromoendoscopy is comparable when methylene

blue or indigo carmine are used as the contrast agent.

57,58

Chromoendoscopy has been compared to standard-

definition endoscopy for detection of neoplasia in both

IBD and non-IBD patients and has been shown to be

superior.

59

Another meta-analysis looked at the diagnostic

accuracy of chromoendoscopy compared to histology and

reported a sensitivity of 83.3 percent and specificity 91.3

percent for chromoendoscopy in detection of intraepithelial

neoplasia.

60

Several randomized studies suggest that

advanced endoscopic imaging modalities may obviate the

need for multiple randombiopsies for dysplasia surveillance

in IBD patients with chronic colitis.

Virtual chromoendoscopy technologieshavebeendeveloped

as an alternative to dye based chromoendoscopy. Virtual

chromoendoscopy relies on the use of selective light filters

and post-image processing techniques to highlight vessel and

crypt architecture by altering the light that is emitted to the

mucosa. Commercially available virtual chromoendoscopy

techniques are narrowband imaging (NBI; Olympus, Tokyo,

Japan), i-scan (Pentax,Tokyo, Japan), Fuji IntelligentChromo

Endoscopy (FICE; Fujinon, Tokyo, Japan).

61

Confocal laser endomicroscopy is another advanced

imaging technique that makes histologic assessment possible

at the cellular and subcellular levels during endoscopy.

62

The potential application of confocal laser endomicroscopy

in IBD patients will be in combination with white-light

endoscopy or chromoendoscopy.

Advanced endoscopic imaging modalities including

high-definition endoscopy, chromoendoscopy, virtual

chromoendoscopy and confocal laser endomicroscopy have

the potential to significantly improve the detection of flat

and subtle dysplasia without the need for random biopsies.

In addition, these novel techniques aid in decision-making

and make it possible to resect a potentially dysplastic or

neoplastic lesion at the time of CRC screening, even before

having the results of biopsy.

63

Conclusion:

Endoscopy is fundamental to the care of patients with

inflammatory bowel disease (IBD) and is essential for

diagnosing and treating both Crohn’s disease (CD) and

ulcerative colitis (UC). Endoscopy is used to make an

initial diagnosis of IBD, distinguish CD from UC, assess

disease extent and activity, monitor response to therapy,

survey for dysplasia, and provide endoscopic treatment

strictures. The new advances in endoscopy resulted in a

major paradigm shift in how we diagnose and treat patients

with IBD. Endoscopy as a historic diagnostic tool has been

turned into an essential mean in surveillance and treatment

of patients with IBD.

v

References

1. Markowitz J, Kahn E, Grancher K, Hyams J, Treem W,

et al. Atypical rectosigmoid histology in children with

newly diagnosed ulcerative colitis.

Am J Gastroenterol.

1993 Dec;88(12):2034–7.

2. Robert ME, Skacel M, Ullman T, Bernstein CN, et al.

Patterns of colonic involvement at initial presentation in

ulcerative colitis: a retrospective study of 46 newly diag-

nosed cases.

Am J Clin Pathol.

2004 July;122(1):94–9.

3. Robert ME, Tang L, Hao LM, Reyes-Mugica M. Pat-

terns of inflammation in mucosal biopsies of ulcerative

colitis: perceived differences in pediatric populations are

limited to children younger than 10 years.

Am J Surg

Pathol.

2004 Feb;28(2):183–9.

4. Odze R, Antonioli D, Peppercorn M, et al. Effect of

topical 5-aminosalicylic acid (5-ASA) therapy on rectal

mucosal biopsy morphology in chronic ulcerative coli-

tis.

Am J Surg Pathol.

1993 Sept;17(9):869–75.

5. Fefferman DS, Farrell RJ. Endoscopy in inflamma-

tory bowel disease: indications, surveillance, and use

in clinical practice.

Clin Gastroenterol Hepatol.

2005

Jan;3(1):11–24.